REMUS BULLARD: Open Payments
NPI 1790728145 · HICKORY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,811 in 90 payments from 29 companies in 2025. Trend: 2023 $1,423 · 2024 $1,319 · 2025 $1,811
Food & beverage: $1,811
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 8 | $146 |
| Ascendis Pharma Endocrinology Inc | 6 | $138 |
| SANOFI-AVENTIS U.S. LLC | 4 | $111 |
| Lilly USA, LLC | 6 | $107 |
| Novo Nordisk Inc | 6 | $103 |
| Amgen Inc. | 6 | $98 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $79 |
| IBSA Pharma Inc. | 3 | $78 |
| BETA BIONICS, INC. | 3 | $76 |
| Radius Health, Inc. | 3 | $74 |
Products named: Korlym, Yorvipath, TZIELD, JARDIANCE, ISTURISA, Tirosint, iLet Bionic Pancreas, Tymlos.
Industry payments across NC — which companies pay providers there.
